COL13A1
Basic information
Region (hg38): 10:69801880-69964275
Links
Phenotypes
GenCC
Source:
- congenital myasthenic syndrome 19 (Strong), mode of inheritance: AR
- congenital myasthenic syndrome 19 (Strong), mode of inheritance: AR
- congenital myasthenic syndrome 19 (Strong), mode of inheritance: AR
- postsynaptic congenital myasthenic syndrome (Supportive), mode of inheritance: AR
- presynaptic congenital myasthenic syndrome (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myasthenic syndrome, congenital, 19 | AR | Musculoskeletal | Individuals are affected by muscular weakness, including affecting the respiratory system, and medical management (with 3,4-diaminopyridine and salbutamol) has been reported as beneficial | Craniofacial; Musculoskeletal; Neurologic | 26626625 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (8 variants)
- Congenital myasthenic syndrome 19 (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COL13A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 93 | 102 | ||||
missense | 161 | 170 | ||||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 14 | 16 | ||||
splice region | 26 | 43 | 11 | 80 | ||
non coding | 12 | 149 | 93 | 256 | ||
Total | 10 | 19 | 182 | 245 | 104 |
Highest pathogenic variant AF is 0.0000131
Variants in COL13A1
This is a list of pathogenic ClinVar variants found in the COL13A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-69802014-G-A | Benign (May 10, 2021) | |||
10-69802338-C-T | Benign (May 11, 2021) | |||
10-69802429-A-G | COL13A1-related disorder | Likely benign (Oct 11, 2023) | ||
10-69802430-G-A | Uncertain significance (May 31, 2021) | |||
10-69802435-G-A | Likely benign (Oct 16, 2023) | |||
10-69802436-C-T | Uncertain significance (Aug 27, 2021) | |||
10-69802447-A-G | Likely benign (Dec 01, 2023) | |||
10-69802448-G-A | Inborn genetic diseases | Uncertain significance (Apr 23, 2024) | ||
10-69802450-G-A | Likely benign (Aug 18, 2023) | |||
10-69802452-C-T | Uncertain significance (Mar 23, 2021) | |||
10-69802458-C-G | Uncertain significance (Feb 21, 2022) | |||
10-69802473-CTGGGGAGT-C | Pathogenic (Nov 10, 2021) | |||
10-69802475-GG-AA | Uncertain significance (Oct 04, 2022) | |||
10-69802489-G-A | COL13A1-related disorder | Likely benign (Dec 13, 2021) | ||
10-69802489-G-T | Likely benign (Sep 07, 2022) | |||
10-69802490-C-A | COL13A1-related disorder | Likely benign (Dec 19, 2023) | ||
10-69802492-C-G | Likely benign (Feb 02, 2022) | |||
10-69802497-CG-C | Pathogenic (May 23, 2023) | |||
10-69802507-G-A | Likely benign (Jun 23, 2022) | |||
10-69802513-G-T | Likely benign (Sep 01, 2022) | |||
10-69802516-G-A | Likely benign (Oct 13, 2022) | |||
10-69802525-G-T | Uncertain significance (Jul 27, 2021) | |||
10-69802532-G-A | Uncertain significance (Mar 18, 2022) | |||
10-69802535-C-T | Inborn genetic diseases | Uncertain significance (May 21, 2024) | ||
10-69802536-G-C | Inborn genetic diseases | Uncertain significance (Aug 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COL13A1 | protein_coding | protein_coding | ENST00000398978 | 39 | 162388 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.74e-14 | 0.999 | 124458 | 0 | 218 | 124676 | 0.000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.770 | 364 | 408 | 0.893 | 0.0000226 | 4405 |
Missense in Polyphen | 238 | 273.89 | 0.86895 | 2905 | ||
Synonymous | -1.23 | 168 | 149 | 1.13 | 0.00000851 | 1498 |
Loss of Function | 3.05 | 31 | 55.6 | 0.558 | 0.00000255 | 684 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00517 | 0.00517 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000396 | 0.000389 |
Finnish | 0.0000465 | 0.0000464 |
European (Non-Finnish) | 0.000234 | 0.000230 |
Middle Eastern | 0.000396 | 0.000389 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00132 | 0.00132 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in cell-matrix and cell-cell adhesion interactions that are required for normal development. May participate in the linkage between muscle fiber and basement membrane. May play a role in endochondral ossification of bone and branching morphogenesis of lung. Binds heparin. At neuromuscular junctions, may play a role in acetylcholine receptor clustering (PubMed:26626625). {ECO:0000250|UniProtKB:Q9R1N9, ECO:0000269|PubMed:10865988, ECO:0000269|PubMed:11956183, ECO:0000269|PubMed:26626625}.;
- Pathway
- Protein digestion and absorption - Homo sapiens (human);Vitamin D Receptor Pathway;Collagen chain trimerization;Collagen biosynthesis and modifying enzymes;Integrin cell surface interactions;Collagen formation;Extracellular matrix organization
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.0355
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.6
Haploinsufficiency Scores
- pHI
- 0.283
- hipred
- Y
- hipred_score
- 0.605
- ghis
- 0.534
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.205
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Col13a1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- morphogenesis of a branching structure;endochondral ossification;cell-matrix adhesion;cell differentiation;extracellular matrix organization;collagen catabolic process;cell-cell adhesion
- Cellular component
- extracellular region;collagen type XIII trimer;extracellular space;endoplasmic reticulum lumen;plasma membrane;cell-cell junction;extracellular matrix;postsynaptic membrane;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent;protein binding;heparin binding;extracellular matrix structural constituent conferring tensile strength